Senior insider sale
Chief Commercial Officer at AXSOME THERAPEUTICS, INC. — senior position signals high conviction
$1.37M
7.50K shares
What this filing means
MAIZEL ARI plans to sell 7.50K shares of AXSOME THERAPEUTICS, INC. valued at approximately $1.37M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/22/2026ACC: 0001921094-26-000410
Officer· Chief Commercial Officer
Since Feb 2026
7.50K
Shares to sell
$1.37M
Approx. market value
7.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Employee Stock Option Exercise
Broker Payment for Cashless Exercise
4/22/2026
7.50KTotal acquired7.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/22/2026 | Employee Stock Option Exercise Broker Payment for Cashless Exercise | 7.50K | — |
| Total | 7.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.50K
Market value
$1.37M
4/22/2026
Total
Units
7.50K
Value
$1.37M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/22/2026 | 7.50K | $1.37M | NASDAQ | Planned |
| Total | 7.50K | $1.37M | ||